Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets. Cosmos Health recently had several announcements, including positive results from an antimicrobial product study. We believe these announcements add to the case for COSM being undervalued at current prices.
